Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,097.03
1,249.03
773.69
594.19
593.17
500.92
659.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,097.03
1,249.03
773.69
594.19
593.17
500.92
659.83
Raw Material Cost
267.72
200.15
142.95
71.04
102.82
85.91
68.67
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
129.34
44.40
40.25
38.65
38.97
34.38
33.26
Selling and Distribution Expenses
325.37
322.08
323.31
239.95
295.34
220.99
248.40
Other Expenses
24.29
31.44
28.34
22.65
26.12
23.65
26.09
Total Expenditure (Excl Depreciation)
965.32
881.04
789.89
576.11
698.33
577.82
611.21
Operating Profit (PBDIT) excl Other Income
131.7
368
-16.200000000000003
18.1
-105.19999999999999
-76.9
48.6
Other Income
23.27
19.19
36.35
37.86
20.44
38.89
29.12
Operating Profit (PBDIT)
168.49
400.98
34.09
70.35
-70.55
-24.03
92.74
Interest
129.34
44.40
40.25
38.65
38.97
34.38
33.26
Exceptional Items
135.49
-103.81
-15.26
-58.89
-70.27
-36.27
-55.64
Gross Profit (PBDT)
829.31
1,048.87
630.74
523.15
490.35
415.01
591.15
Depreciation
13.51
13.80
13.94
14.40
14.17
13.98
15.00
Profit Before Tax
161.14
238.97
-35.36
-41.60
-193.96
-108.66
-11.17
Tax
-25.28
-12.12
30.92
15.88
-110.19
2.91
5.72
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
186.42
251.08
-66.28
-57.48
-83.76
-111.57
-16.89
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
186.42
251.08
-66.28
-57.48
-83.76
-111.57
-16.89
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
186.42
251.08
-66.28
-57.48
-83.76
-111.57
-16.89
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
789.18
233.89
250.59
115.44
67.09
32.35
-3.07
Earnings per share (EPS)
1.37
1.84
-0.51
-0.44
-0.65
-0.87
-0.13
Diluted Earnings per share
1.37
1.84
-0.51
-0.44
-0.65
-0.87
-0.13
Operating Profit Margin (Excl OI)
12.01%
29.46%
-2.09%
3.04%
-17.73%
-15.35%
7.37%
Gross Profit Margin
15.92%
20.24%
-2.77%
-4.58%
-30.31%
-18.9%
0.58%
PAT Margin
16.99%
20.1%
-8.57%
-9.67%
-14.12%
-22.27%
-2.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is -12.17% vs 61.43% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -25.77% vs 478.73% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is -61.97% vs 16,700.00% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 191.22% vs 10.45% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
Compare Quarterly Results Of Alnylam Pharmaceuticals, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
1,097.03
944.96
152.07
16.09%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,097.03
944.96
152.07
16.09%
Raw Material Cost
267.72
219.96
47.76
21.71%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
129.34
16.53
112.81
682.46%
Selling and Distribution Expenses
325.37
433.22
-107.85
-24.89%
Other Expenses
24.29
13.35
10.94
81.95%
Total Expenditure (Excl Depreciation)
965.32
803.21
162.11
20.18%
Operating Profit (PBDIT) excl Other Income
131.72
141.75
-10.03
-7.08%
Other Income
23.27
-0.32
23.59
7,371.88%
Operating Profit (PBDIT)
168.49
237.73
-69.24
-29.13%
Interest
129.34
16.53
112.81
682.46%
Exceptional Items
135.49
10.35
125.14
1,209.08%
Gross Profit (PBDT)
829.31
725.00
104.31
14.39%
Depreciation
13.51
96.30
-82.79
-85.97%
Profit Before Tax
161.14
135.25
25.89
19.14%
Tax
-25.28
8.18
-33.46
-409.05%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
186.42
127.07
59.35
46.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
186.42
127.07
59.35
46.71%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
186.42
127.07
59.35
46.71%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
789.18
5,310.96
-4,521.78
-85.14%
Earnings per share (EPS)
1.37
0.54
0.83
153.70%
Diluted Earnings per share
1.37
0.54
0.83
153.70%
Operating Profit Margin (Excl OI)
12.01%
15.00%
0.00
-2.99%
Gross Profit Margin
15.92%
24.50%
0.00
-8.58%
PAT Margin
16.99%
13.45%
0.00
3.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 109.70 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -12.17% vs 61.43% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 84.93% vs 34.91% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 18.64 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -25.77% vs 478.73% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 322.43% vs 39.23% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.52 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -61.97% vs 16,700.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 259.56% vs 11.56% in Dec 2024
Quarterly - Interest
Interest 12.93 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 191.22% vs 10.45% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 231.54% vs 24.60% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.01%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
